Matthew Baker Joins Spectroscopy’s Editorial Advisory Board

Spectroscopy magazine is pleased to announce the addition of Matthew Baker to its editorial advisory board.

Baker received his PhD in 2007 from the University of Manchester (England) and currently is a senior lecturer in chemistry at the University of Strathclyde in Glasgow, Scotland. He leads interdisciplinary research based on fundamental studies to advance the application of analytical chemistry to real-world problems in biomedical, clinical, defense, and security areas. His primary focus is on the development of spectroscopic and spectrometric molecular pathology, disease diagnosis, and the detection of pathogenic bacteria and toxic chemicals.

A pioneer in the use of vibrational spectroscopy for clinical diagnostics, Baker has developed an accurate, reproducible, and repeatable method using vibrational spectroscopy for brain tumor diagnosis that is suitable for clinical applications. He is now expanding this approach using novel light sources to enable rapid, high-throughput imaging.

In addition to key papers that Baker has contributed to the field, he has organized, chaired, and developed clinical spectroscopy sessions at the SciX conference, co-organized a Faraday discussion of the Royal Society of Chemistry on “Advanced Vibrational Spectroscopy for Biomedical Applications,” and has co-written a concise physics e-book for the Institute of Physics. He has guest edited three journal issues.

Baker recently co-initiated and co-formed the UK Clinical Infrared and Raman Spectroscopy (CLIRSPEC) Network, which resulted in the emergence of the charitable International Society for Clinical Spectroscopy. He is a member of Raman4Clinics, a European consortium focused on the use of Raman spectroscopy in the clinic. He has also developed the CLIRSPEC Summer School, a provider of an interdisciplinary education to students interested in clinical spectroscopy.

Baker also received the 2016 Emerging Leader in Molecular Spectroscopy award from Spectroscopy magazine.